177
Views
7
CrossRef citations to date
0
Altmetric
Review

HIV-associated nephropathy: links, risks and management

, , , , , & show all
Pages 73-81 | Published online: 25 May 2018

References

  • MocroftAReissPGasiorowskiJSerious fatal and nonfatal non-AIDS-defining illnesses in EuropeJ Acquir Immune Defic Syndr201055226227020700060
  • WaheedSAttaMGPredictors of HIV-associated nephropathyExpert Rev Anti Infect Ther201412555556324655211
  • FogoABLuscoMANajafianBAlpersCEAJKD atlas of renal pathology: HIV-associated nephropathy (HIVAN)Am J Kidney Dis2016682e13e1427477363
  • SwanepoelCRAttaMGD’AgatiVDKidney disease in the setting of HIV infection: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conferenceKidney Int201893354555929398134
  • AhujaTSBoruckiMFuntanillaMShahinianVHollanderMRajaramanSIs the prevalence of HIV-associated nephropathy decreasing?Am J Nephrol199919665565910592359
  • Razzak ChaudharySWorkenehBTMontez-RathMEZolopaARKlotmanPEWinkelmayerWCTrends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathyNephrol Dial Transplantat2015301017341740
  • GenoveseGFriedmanDJRossMDAssociation of trypanolytic ApoL1 variants with kidney disease in African AmericansScience2010329599384184520647424
  • KoW-YRajanPGomezFIdentifying darwinian selection acting on different human APOL1 variants among diverse African populationsAm J Hum Genet2013931546623768513
  • KoppJBNelsonGWSampathKAPOL1 Genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathyJ Am Soc Nephrol201122112129213721997394
  • LipkowitzMSFreedmanBILangefeldCDApolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African AmericansKidney Int201383111412022832513
  • BeckermanPBi-KarchinJParkATransgenic expression of human APOL1 risk variants in podocytes induces kidney disease in miceNat Med234429438
  • GranadoDMullerDKrauselVIntracellular APOL1 risk variants cause cytotoxicity accompanied by energy depletionJ Am Soc Nephrol201728113227323828696248
  • OlabisiOAZhangJYVerPlankLAPOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinasesProc Natl Acad Sci USA2016113483083726699492
  • MaLChouJWSnipesJAAPOL1 renal-risk variants induce mitochondrial dysfunctionJ Am Soc Nephrol20172841093110527821631
  • FuYZhuJRichmanAAPOL1-G1 Nephrocytes induces hypertrophy and accelerates cell deathJ Am Soc Nephrol20172841106111627864430
  • Kruzel-DavilaEShemerROfirAAPOL1-mediated cell injury involves disruption of conserved trafficking processesJ Am Soc Nephrol20172841117113027864431
  • Kruzel-DavilaEWasserWGAviramSSkoreckiKAPOL1 nephropathy: from gene to mechanisms of kidney injuryNephrol Dial Transplant201631334935825561578
  • RyomLKirkOLundgrenJDAdvanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in EuropeHIV Med201314850350823590641
  • NadkarniGNKonstantinidisIWyattCMHIV and the aging kidneyCurr Opin HIV AIDS20149434034524824884
  • CheungCYWongKMLeeMPPrevalence of chronic kidney disease in Chinese HIV-infected patientsNephrol Dial Transplant200722113186319017575315
  • YanagisawaNAndoMAjisawaAClinical characteristics of kidney disease in Japanese HIV-infected patientsNephron Clin Pract20111183c285c29121212692
  • BigeNLanternierFViardJ-PPresentation of HIV-associated nephropathy and outcome in HAART-treated patientsNephrol Dial Transplant20112731114112121745806
  • AttaMGChoiMJLongeneckerJCNephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathyAm J Med2005118111288
  • U.S. Renal Data SystemUSRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United StatesBethesda, MDNational Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases2007
  • CoreshJByrd-HoltDAstorBCChronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000J Am Soc Nephrol200516118018815563563
  • BrownTTColeSRLiXAntiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort studyArch Intern Med2005165101179118415911733
  • BrownTTLiXColeSRCumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort StudyAIDS200519131375138316103768
  • TienPCSchneiderMFColeSRAntiretroviral therapy exposure and incidence of diabetes mellitus in the Women’s Interagency HIV StudyAIDS200721131739174517690572
  • GazzarusoCBrunoRGarzanitiAHypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndromeJ Hypertens20032171377138212817187
  • JungOBickelMDittingTHypertension in HIV-1-infected patients and its impact on renal and cardiovascular integrityNephrol Dial Transplant20041992250225815238630
  • LescureFXFlateauCPacanowskiJHIV-associated kidney glomerular diseases: changes with time and HAARTNephrol Dial Transplant20122762349235522248510
  • AttaMGLongeneckerJCFineDMSonography as a predictor of human immunodeficiency virus–associated nephropathyJ Ultrasound Med200423560361015154526
  • BerlinerARFineDMLucasGMObservations on a cohort of HIV-infected patients undergoing native renal biopsyAm J Nephrol20082847848618176076
  • WilliamsDIWilliamsDJWilliamsIGUnwinRJGriffithsMHMillerRFPresentation, pathology, and outcome of HIV associated renal disease in a specialist centre for HIV/AIDSSex Transm Infect19987431791849849552
  • EstrellaMFineDMGallantJEHIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patientsClin Infect Dis200643337738016804855
  • IzzedineHAcharyaVWirdenMRole of HIV-1 DNA levels as clinical marker of HIV-1-associated nephropathiesNephrol Dial Transplant201026258058320624771
  • EitnerFCuiYHudkinsKLChemokine receptor (CCR5) expression in human kidneys and in the HIV infected macaqueKidney Int1998546194519549853259
  • DianaNENaickerSUpdate on current management of chronic kidney disease in patients with HIV infectionInt J Nephrol Renovasc Dis2016922323427695357
  • HatsukariISinghPHitosugiNDEC-205-Mediated internalization of HIV-1 results in the establishment of silent infection in renal tubular cellsJ Am Soc Nephrol200718378078717287423
  • AttaMGGallantJERahmanMHAntiretroviral therapy in the treatment of HIV-associated nephropathyNephrol Dial Transplantat2006211028092813
  • LucasGMEustaceJASozioSMentariEKAppiahKAMooreRDHighly active antiretroviral therapy and the incidence of HIV-1-associated nephropathyAIDS200418354154615090808
  • PostFACampbellLJHamzahLPredictors of renal outcome in HIV-associated nephropathyClin Infect Dis20084681282128918444868
  • CasasJPChuaWLoukogeorgakisSEffect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysisLancet200536695022026203316338452
  • AlsauskasZCMedapalliRKRossMJExpert opinion on pharmacotherapy of kidney disease in HIV-infected patientsExpert Opin Pharmacother201112569170421250871
  • KimmelPLMishkinGJUmanaWOCaptopril and renal survival in patients with human immunodeficiency virus nephropathyAm J Kidney Dis19962822022088768914
  • WeiABurnsGCWilliamsBAMohammedNBVisintainerPSivakSLLong-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibitionKidney Int20036441462147112969167
  • LucasGMRossMJStockPGHIV Medicine Association of the Infectious Diseases Society of America Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of AmericaClin Infect Dis2014599e96e13825234519
  • EustaceJANuermbergerEChoiMScheelPJJrMooreRBriggsWACohort study of the treatment of severe HIV-associated nephropathy with corticosteroidsKidney Int20005831253126010972688
  • LaradiAMalletABeaufilsHAllouacheMMartinezFHIV-associated nephropathy: outcome and prognosis factorsJ Am Soc Nephrol1998912232723359848787
  • JotwaniVLiYGrunfeldCChoiAIShlipakMGRisk factors for ESRD in HIV-infected individuals: traditional and HIV-related factorsAm J Kidney Dis201259562863522206742
  • RaschMGHellebergMFeldt-RasmussenBIncreased risk of dialysis and end-stage renal disease among HIV patients in Denmark compared with the background populationNephrol Dial Transplant20142961232123823975841
  • DaveMBShabihKBlumSMaintenance hemodialysis in patients with HIV-associated nephropathyClin Nephrol1998506367749877110
  • AttaMGFineDMKirkGDMehtaSHMooreRDLucasGMSurvival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, MarylandClin Infect Dis200745121625163218190325
  • CuriMAPappasPJSilvaMBJrHemodialysis access: influence of the human immunodeficiency virus on patency and infection ratesJ Vasc Surg199929460861610194487
  • Recommendations for preventing transmission of infections among chronic hemodialysis patientsMMWR Recomm Rep200150RR-5143
  • StockPGBarinBMurphyBOutcomes of kidney transplantation in HIV-infected recipientsN Engl J Med2010363212004201421083386
  • WaheedSSakrAChhedaNDOutcomes of Renal Transplantation in HIV-1 Associated NephropathyPLoS One2015106e012970226061701
  • MullerEBardayZMendelsonMKahnDHIV-positive-to-HIV-positive kidney transplantation–results at 3 to 5 yearsN Engl J Med201537261362025671253
  • DurandCMSegevDSugarmanJRealizing HOPE: the ethics of organ transplantation from HIV-positive donorsAnn Intern Med201616513814227043422
  • MullerEBardayZHIV-positive donor selection for HIV-positive transplant recipientsJ Am Soc Nephrol Epub2018112
  • FineDMPerazellaMALucasGMAttaMGKidney biopsy in HIV: beyond HIV-associated nephropathyAm J Kidney Dis200851350451418295067
  • JamesPAOrtizECarterBL2014 evidence-based guideline for the management of high blood pressure in adults: (JNC8)JAMA2014311550752024352797
  • PhilipGreenlandEricPetersonThe New 2017 ACC/AHA guidelines “up the pressure” on diagnosis and treatment of hypertensionJAMA2017318212083208429159417